These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31760216)

  • 1. Estimating the future burden of hip fractures in Norway. A NOREPOS study.
    Hagen G; Magnussen J; Tell G; Omsland T
    Bone; 2020 Feb; 131():115156. PubMed ID: 31760216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forecasting the burden of future postmenopausal hip fractures.
    Omsland TK; Magnus JH
    Osteoporos Int; 2014 Oct; 25(10):2493-6. PubMed ID: 24980184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Total Hip Replacements on the Incidence of Hip Fractures in Norway During 1999-2019. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study.
    Kjeldgaard HK; Meyer HE; O'Flaherty M; Apalset EM; Dahl C; Emaus N; Fenstad AM; Furnes O; Gjertsen JE; Hoff M; Schei B; Søgaard AJ; Tell GS; Holvik K
    J Bone Miner Res; 2022 Oct; 37(10):1936-1943. PubMed ID: 35877138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued decline in hip fracture incidence in Norway: a NOREPOS study.
    Søgaard AJ; Holvik K; Meyer HE; Tell GS; Gjesdal CG; Emaus N; Grimnes G; Schei B; Forsmo S; Omsland TK
    Osteoporos Int; 2016 Jul; 27(7):2217-2222. PubMed ID: 26902091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future burden of incident hip fractures in New South Wales, Australia.
    Stephens AS; Toson B; Close JC
    Arch Osteoporos; 2014; 9():200. PubMed ID: 25385340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of elevation and residential proximity to the coast in explaining geographic variations in hip fracture incidence. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study.
    Dahl C; Madsen C; Omsland TK; Søgaard AJ; Tell GS; Holvik K; Meyer HE
    Osteoporos Int; 2021 May; 32(5):1001-1006. PubMed ID: 33247392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Søgaard AJ; Meyer HE; Emaus N; Grimnes G; Gjesdal CG; Forsmo S; Schei B; Tell GS
    Scand J Public Health; 2014 Dec; 42(8):804-13. PubMed ID: 25278275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study.
    Omsland TK; Holvik K; Meyer HE; Center JR; Emaus N; Tell GS; Schei B; Tverdal A; Gjesdal CG; Grimnes G; Forsmo S; Eisman JA; Søgaard AJ
    Eur J Epidemiol; 2012 Oct; 27(10):807-14. PubMed ID: 22870851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Cold Ambient Temperature With Fracture Risk and Mortality: National Data From Norway-A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study.
    Dahl C; Madsen C; Omsland TK; Søgaard AJ; Tunheim K; Stigum H; Holvik K; Meyer HE
    J Bone Miner Res; 2022 Aug; 37(8):1527-1536. PubMed ID: 35689442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and economic burden of osteoporosis in Switzerland.
    Svedbom A; Ivergård M; Hernlund E; Rizzoli R; Kanis JA
    Arch Osteoporos; 2014; 9():187. PubMed ID: 24970672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future economic burden of osteoporosis in New Zealand.
    Brown P; McNeill R; Leung W; Radwan E; Willingale J
    Appl Health Econ Health Policy; 2011 Mar; 9(2):111-23. PubMed ID: 21271750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium.
    Papadimitriou N; Tsilidis KK; Orfanos P; Benetou V; Ntzani EE; Soerjomataram I; Künn-Nelen A; Pettersson-Kymmer U; Eriksson S; Brenner H; Schöttker B; Saum KU; Holleczek B; Grodstein FD; Feskanich D; Orsini N; Wolk A; Bellavia A; Wilsgaard T; Jørgensen L; Boffetta P; Trichopoulos D; Trichopoulou A
    Lancet Public Health; 2017 May; 2(5):e239-e246. PubMed ID: 29253489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Marques A; Lourenço Ó; da Silva JA;
    Osteoporos Int; 2015 Nov; 26(11):2623-30. PubMed ID: 25986386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hip fractures.
    Kannus P; Parkkari J; Sievänen H; Heinonen A; Vuori I; Järvinen M
    Bone; 1996 Jan; 18(1 Suppl):57S-63S. PubMed ID: 8717549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study.
    Omsland TK; Emaus N; Tell GS; Magnus JH; Ahmed LA; Holvik K; Center J; Forsmo S; Gjesdal CG; Schei B; Vestergaard P; Eisman JA; Falch JA; Tverdal A; Søgaard AJ; Meyer HE
    Bone; 2014 Jun; 63():81-6. PubMed ID: 24607943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of hip fracture in Iran.
    Ahmadi-Abhari S; Moayyeri A; Abolhassani F
    Calcif Tissue Int; 2007 Mar; 80(3):147-53. PubMed ID: 17340222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic variations in hip fracture incidence in a high-risk country stretching into the Arctic: a NOREPOS study.
    Forsén L; Søgaard AJ; Holvik K; Meyer HE; Omsland TK; Stigum H; Dahl C
    Osteoporos Int; 2020 Jul; 31(7):1323-1331. PubMed ID: 32095840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture.
    Johnell O; Kanis JA
    Osteoporos Int; 2004 Nov; 15(11):897-902. PubMed ID: 15490120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in population demographics and the future incidence of hip fracture.
    Holt G; Smith R; Duncan K; Hutchison JD; Reid D
    Injury; 2009 Jul; 40(7):722-6. PubMed ID: 19426972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.